Safety and Tolerability of CMAB017 In Patients With Advanced Solid Tumors

Clinical trial NCT06933069 · RECRUITING

Trial details

NCT number: NCT06933069
Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Malignancies

Start date: 2025-06-09
Primary completion: 2026-05-31
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.